Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $27.1900 (-1.13%) ($26.6700 - $27.5500) on Fri. Jul. 31, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.37% (three month average) | RSI | 53 | Latest Price | $27.1900(-1.13%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | HALO declines -1.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(50%) IBB(49%) IWM(47%) IWC(45%) ARKG(42%) | Factors Impacting HALO price | HALO will decline at least -1.185% in a week (0% probabilities). VIXM(-31%) UUP(-15%) VXX(-14%) EDOC(-4%) TLT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.185% (StdDev 2.37%) | Hourly BBV | 0 () | Intraday Trend | -1.2% | | | |
|
Resistance Level | $27.86 | 5 Day Moving Average | $27.31(-0.44%) | 10 Day Moving Average | $27.56(-1.34%) | 20 Day Moving Average | $27.86(-2.4%) | To recent high | -6.4% | To recent low | 19.1% | Market Cap | $3.716b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |